Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

Offering human papillomavirus (HPV) self-testing in primary care appears to boost cervical cancer screening rates compared with usual care, a cluster-randomized trial in New Zealand showed. A ...

One pillar of the World Health Organization’s (WHO) global cervical cancer elimination strategy includes that at least 70% of women are screened for cervical cancer using a high-performance test. WHO ...

Hologic has received the US Food and Drug Administration (FDA) approval for its Aptima HPV assay for use in clinician-collected primary screening, further expanding its cervical health portfolio. The ...

Screening for cervical cancer is critically important to women’s health. In the United States, it is estimated that in 2026, approximately 13,490 new cases of invasive cervical cancer will be ...

BROWNSVILLE, Texas, Nov. 20, 2024 /PRNewswire/ -- A first of its kind Human Papillomavirus (HPV) self-collection screening pilot program aimed at improving cervical cancer screening in underserved ...

Offering universal human papillomavirus (HPV) self-testing in primary care was both non-inferior and superior to clinician-sampled Pap smear. Underscreened and marginalized groups saw the most benefit ...